使用质谱的血液代谢组学分析已成为研究非癌症疾病和了解其潜在代谢改变的强大方法。血,作为一种容易获得的生理液体,包含来自各种生理系统的各种代谢物。质谱为血液代谢物的综合分析提供了通用和精确的分析平台,包括蛋白质,脂质,肽,聚糖,和免疫球蛋白。在这次全面审查中,我们概述了基于质谱的血液代谢组学分析的研究前景.虽然代谢组学研究领域主要集中在癌症上,这篇综述特别突出了与非癌症疾病相关的研究,旨在引起人们对经常被忽视的有价值研究的关注。采用自然语言处理方法,我们处理了507篇文章,以提供对特定疾病和生理系统的代谢组学研究应用的见解。该综述涵盖了广泛的非癌症疾病,重点是心血管疾病,生殖疾病,糖尿病,炎症,和免疫缺陷状态。通过分析血液样本,研究人员获得了与这些疾病相关的代谢扰动的宝贵见解,可能导致新的生物标志物的鉴定和个性化治疗方法的发展。此外,我们提供了血液代谢组学研究中使用的各种质谱方法的全面概述,包括GC-MS,LC-MS,和其他人讨论他们的优点和局限性。为了扩大范围,我们建议纳入支持GC×GC-MS在基于代谢组学的研究中适用性的最新综述文章。这种增加将有助于更详尽地理解可用的分析技术。将基于质谱的血液分析整合到临床实践中,有望改善疾病诊断,治疗监测,和患者结果。通过解开与非癌症疾病相关的复杂代谢改变,研究人员和医疗保健专业人员可以为精准医疗和个性化治疗干预铺平道路。质谱技术和数据分析方法的不断进步将进一步增强血液代谢组学在非癌症疾病中的潜力,促进其从实验室到常规临床应用的翻译。
Blood metabolomics profiling using mass spectrometry has emerged as a powerful approach for investigating non-cancer diseases and understanding their underlying metabolic alterations. Blood, as a readily accessible physiological fluid, contains a diverse repertoire of metabolites derived from various physiological systems. Mass spectrometry offers a universal and precise analytical platform for the comprehensive analysis of blood metabolites, encompassing proteins, lipids, peptides, glycans, and immunoglobulins. In this comprehensive
review, we present an overview of the research landscape in mass spectrometry-based blood metabolomics profiling. While the field of metabolomics research is primarily focused on cancer, this
review specifically highlights studies related to non-cancer diseases, aiming to bring attention to valuable research that often remains overshadowed. Employing natural language processing methods, we processed 507 articles to provide insights into the application of metabolomic studies for specific diseases and physiological systems. The
review encompasses a wide range of non-cancer diseases, with emphasis on cardiovascular disease, reproductive disease, diabetes, inflammation, and immunodeficiency states. By analyzing blood samples, researchers gain valuable insights into the metabolic perturbations associated with these diseases, potentially leading to the identification of novel biomarkers and the development of personalized therapeutic approaches. Furthermore, we provide a comprehensive overview of various mass spectrometry approaches utilized in blood metabolomics research, including GC-MS, LC-MS, and others discussing their advantages and limitations. To enhance the scope, we propose including recent
review articles supporting the applicability of GC×GC-MS for metabolomics-based studies. This addition will contribute to a more exhaustive understanding of the available analytical techniques. The Integration of mass spectrometry-based blood profiling into clinical practice holds promise for improving disease diagnosis, treatment monitoring, and patient outcomes. By unraveling the complex metabolic alterations associated with non-cancer diseases, researchers and healthcare professionals can pave the way for precision medicine and personalized therapeutic interventions. Continuous advancements in mass spectrometry technology and data analysis methods will further enhance the potential of blood metabolomics profiling in non-cancer diseases, facilitating its translation from the laboratory to routine clinical application.